Literature DB >> 5947250

Metabolism of cu-64-labeled copper by the isolated rat liver.

C A Owen, J B Hazelrig.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5947250     DOI： 10.1152/ajplegacy.1966.210.5.1059

Source DB:  PubMed          Journal:  Am J Physiol        ISSN： 0002-9513


× No keyword cloud information.
  2 in total

1.  In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.

Authors:  Senthil R Kumar; Fabio A Gallazzi; Riccardo Ferdani; Carolyn J Anderson; Thomas P Quinn; Susan L Deutscher
Journal:  Cancer Biother Radiopharm       Date:  2010-12       Impact factor: 3.099

2.  A preliminary clinical trial to evaluate 64Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer.

Authors:  Ilhan Lim; Woo Chul Noh; Inki Lee; Byung Hyun Byun; Byung Il Kim; Chang Woon Choi; Sang-Keun Woo; Kwang Il Kim; Kyo Chul Lee; Joo Hyun Kang; Min-Ki Seong; Hyun-Ah Kim; Sang Moo Lim
Journal:  EJNMMI Res       Date:  2021-01-21       Impact factor: 3.138
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.